Summit Rock Advisors, LP - Q2 2024 holdings

$323 Million is the total value of Summit Rock Advisors, LP's 7 reported holdings in Q2 2024. The portfolio turnover from Q1 2024 to Q2 2024 was 44.4% .

 Value Shares↓ Weighting
VWO SellVANGUARD INTL EQUITY INDEX Fftse emr mkt etf$101,789,523
-3.4%
2,326,086
-7.8%
31.47%
-6.9%
VGK NewVANGUARD INTL EQUITY INDEX Fftse europe etf$69,631,5621,042,857
+100.0%
21.52%
IWP SellISHARES TRrus md cp gr etf$51,615,330
-9.0%
467,742
-5.9%
15.96%
-12.3%
XLE BuySELECT SECTOR SPDR TRenergy$30,216,863
+377.0%
331,507
+394.0%
9.34%
+359.7%
AAPL SellAPPLE INC$29,789,461
-47.3%
141,437
-57.1%
9.21%
-49.2%
NVDA BuyNVIDIA CORPORATION$28,335,134
-49.7%
229,360
+267.8%
8.76%
-51.5%
GOOG SellALPHABET INCcap stk cl c$12,106,637
-44.1%
66,005
-53.6%
3.74%
-46.1%
DAWN ExitDAY ONE BIOPHARMACEUTICALS I$0-51,502
-100.0%
-0.27%
AMZN ExitAMAZON COM INC$0-11,320
-100.0%
-0.66%
MSFT ExitMICROSOFT CORP$0-14,053
-100.0%
-1.90%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2024-07-25
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ISHARES TR29Q3 202090.6%
ISHARES TR26Q4 202051.7%
ISHARES INC11Q1 202064.0%
ISHARES TR11Q4 202147.6%
SELECT SECTOR SPDR TR ENERGY9Q2 202467.4%
ISHARES TR9Q2 201534.5%
PHATHOM PHARMACEUTICALS INC9Q2 20221.1%
ISHARES TR RUS 2000 VAL ETF7Q4 202247.0%
ISHARES TR5Q2 202427.2%
VANGUARD INTL EQUITY INDEX F5Q3 202245.3%

View Summit Rock Advisors, LP's complete holdings history.

Latest filings
TypeFiled
N-PX2024-08-01
13F-HR2024-07-25
13F-HR2024-05-08
13F-HR2024-01-26
13F-HR2023-10-24
13F-HR2023-07-21
13F-HR2023-05-09
13F-HR2023-01-12
13F-HR2022-11-02
13F-HR2022-08-01

View Summit Rock Advisors, LP's complete filings history.

Compare quarters

Export Summit Rock Advisors, LP's holdings